EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Syros Pharmaceuticals's enterprise value is $2.67 Mil.
Syros Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $0.39 Mil. Therefore, Syros Pharmaceuticals's EV-to-Revenue for today is 6.91.
The historical rank and industry rank for Syros Pharmaceuticals's EV-to-Revenue or its related term are showing as below:
SYRS'
s EV-to-Revenue Range Over the Past 10 Years
Min: -6.41 Med: 43.59 Max: 1194.31
Current: 6.91
During the past 10 years, the highest EV-to-Revenue of Syros Pharmaceuticals was 1194.31. The lowest was -6.41. And the median was 43.59.
SYRS's EV-to-Revenue is ranked better than 51.96% of 995
companies
in the Biotechnology industry
Industry Median: 7.63
vs SYRS: 6.91
Syros Pharmaceuticals EV-to-Revenue Historical Data
The historical data trend for Syros Pharmaceuticals's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Syros Pharmaceuticals's EV-to-Revenue
For the Biotechnology subindustry, Syros Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syros Pharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Syros Pharmaceuticals's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Syros Pharmaceuticals's EV-to-Revenue falls into.
Syros Pharmaceuticals's current Enterprise Value is $2.67 Mil.
Syros Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syros Pharmaceuticals's share price for today is $0.025.
Syros Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syros Pharmaceuticals EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Syros Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SYRS has been successfully added to your 